Torrent Pharma to acquire Curatio for $245.16m
The latest takeover is anticipated to boost the presence of Torrent in the dermatology segment.
Dermatology
Latest in
Dermatology
How environmental factors could influence disease and drugs
Environmental and social exposures can majorly affect human health, and researchers are now finding ways to use that understanding in…
By
EC grants approval for BMS’ Opdualag to treat melanoma
In the Opdualag arm, median PFS was 6.7 months versus three months for subjects who were given nivolumab monotherapy.
US FDA grants approval for BMS’ Sotyktu to treat plaque psoriasis
The approval is based on data from the Phase III POETYK PSO-1 and POETYK PSO-2 trials.
BMS reports 2% rise in total revenue in Q2 2022
Revenues grew 12% to $8.3bn in the US for the three months ended on 30 June.
Quoin and Endo sign supply deal for QRX003 in Canada
Under the supply deal, Quoin is entitled for manufacturing and supplying QRX003 to Endo.
Health Canada to review Arcutis’ roflumilast cream NDS for plaque psoriasis
The NDS submission is based on positive findings from the Phase III programme and two long-term trials of roflumilast cream…
Alopecia: Can new treatments pass the innovation and safety bar?
Despite a safety disclosure for one of the two anti-baldness assets on the market, demand for new treatments remains strong.
By